ZORYVE: payments to doctors
Payments that named ZORYVE as the associated drug or biological, reported under the Sunshine Act for program years 2019–2025.
- Total reported
- $13M
- Providers
- 26,242
- Transactions
- 131,891
- Average per transaction
- $99
The per-transaction average — $99 — is the number that tells you what kind of spending this is. A few dollars means meals at product presentations, reported by the thousand. Hundreds or thousands means consulting, speaking or royalty arrangements with a much smaller group of physicians. Across all 26,242 providers the average total is $497, but that average hides a very steep distribution.
Companies reporting these payments
| Company | Total reported | Share |
|---|---|---|
| Arcutis Biotherapeutics, Inc. | $11,926,268 | 91.4% |
| Kowa Pharmaceuticals America, Inc. | $1,120,849 | 8.6% |